The hormone-bound Vitamin D receptor enhances the FBW7-dependent turnover of NF-κ B subunits

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Fekrmandi, Fatemeh ^a   Wang, Tian Tian ^a   White, John H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,25-DIHYDROXYVITAMIN D; CALCITRIOL; CALCITRIOL RECEPTOR; CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NUCLEAR PROTEIN; TPX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA; UBIQUITIN PROTEIN LIGASE; VITAMIN D;

ANALOGS AND DERIVATIVES; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HT-29 CELL LINE; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

CALCITRIOL; CELL CYCLE PROTEINS; F-BOX PROTEINS; GENE EXPRESSION REGULATION; HORMONES; HT29 CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NF-KAPPA B P52 SUBUNIT; NUCLEAR PROTEINS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; UBIQUITIN-PROTEIN LIGASES; VITAMIN D;

EID: 84939430573     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13002     Document Type: Article

References (64)

1. Krishnan, A. V. & Feldman, D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu. Rev. Pharmacol. Toxicol. 51, 311-336 (2011).
2. Feldman, D., Malloy, P., Krishnan, A. & Balint, E. Vitamin D: biology, action and clinical implications. Osteoporosis 1, 317-382 (2007).
3. Tavera-Mendoza, L. E. & White, J. H. Cell defenses and the sunshine vitamin. Sci. Am. 297, 62-72 (2007).
4. Wang, T.-T. et al. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173, 2909-2912 (2004).
5. Etten, E. V. & Mathieu, C. Immunoregulation by 1, 25-dihydroxyvitamin D3: Basic concepts. J. Steroid. Biochem. Mol. Biol. 97, 93-101 (2005).
6. Cantorna, M. T., Zhu, Y., Froicu, M. & Wittke, A. Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 80, 1717S-1720S (2004).
7. Cantorna, M. T. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 92, 60-64 (2006).
8. Hossein-nezhad, A., Spira, A. & Holick, M. F. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One 8, e58725 (2013).
9. Holick, M. F. High prevalence of vitamin D inadequecy and implications for health. Mayo. Clin. Proc. 81, 353-373 (2006).
10. Łuczyńska, A. et al. Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 98, 827-838 (2013).
11. Camargo, C. A. et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 130, e561-e567 (2012).
12. Guyton, K. Z., Kensler, T. W. & Posner, G. H. Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu. Rev. Pharmacol. Toxicol. 41, 421-442 (2001).
13. Sanchez, R., Nguyen, D., Rocha, W., White, J. H. & Mader, S. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 24, 244-254 (2002).
14. Wang, T.-T. et al. Large-scale in silico and microarray-based identification of direct 1, 25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 19, 2685-2695 (2005).
15. Moukayed, M. & Grant, W. B. Molecular link between vitamin D and cancer prevention. Nutrients 5, 3993-4021 (2013).
16. Pike, J. & Meyer, M. B. Fundamentals of vitamin D hormone-regulated gene expression. J. Steroid. Biochem. Mol. Biol. 14, 5-11 (2013).
17. Dimitrov, V., Salehi-Tabar, R., An, B.-S. & White, J. H. Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: Insights into calcium homeostasis, immune system regulation and cancer chemoprevention. J. Steroid. Biochem. Mol. Biol. 109, 18827-18832 (2013).
18. Lu, X., Farmer, P., Rubin, J. & Nanes, M. S. Integration of the Nfκ B p65 subunit into the vitamin D receptor transcriptional complex: Identification of p65 domains that inhibit 1, 25-dihydroxyvitamin D3-stimulated transcription. J. Cell. Biochem. 92, 833-848 (2004).
19. Szeto, F. L. et al. Involvement of the vitamin D receptor in the regulation of NF-κ B activity in fibroblasts. J. Steroid. Biochem. Mol. Biol. 103, 563-566 (2007).
20. Wang, T.-T. et al. Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β 2 innate immune pathway defective in crohn disease. J. Biol. Chem. 285, 2227-2231 (2010).
21. Baud, V. & Karin, M. Is NF-κ B a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 8, 33-40 (2009).
22. Perkins, N. D. Integrating cell-signalling pathways with NF-κ B and IKK function. Nat. Rev. Mol. Cell. Biol. 8, 49-62 (2007).
23. Perkins, N. D. The diverse and complex roles of NF-κ B subunits in cancer. Nat. Rev. Cancer 12, 121-132 (2012).
24. Karin, M. Nuclear factor-κ B in cancer development and progression. Nature 441, 431-436 (2006).
25. Kim, H., Hawke, N. & Baldwin, A. NF-κ B and IKK as therapeutic targets in cancer. Cell. Death. Differ. 13, 738-747 (2006).
26. Karin, M., Cao, Y., Greten, F. R. & Li, Z.-W. NF-κ B in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2, 301-310 (2002).
27. Busino, L. et al. Fbxw7 [alpha]-and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nat. Cell. Biol. 14, 375-385 (2012).
28. Palayoor, S., Youmell, M., Calderwood, S., Coleman, C. & Price, B. Constitutive activation of IkappaB kinase alpha and NFkappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18, 7389-7394 (1999).
29. Ben-Neriah, Y. & Karin, M. Inflammation meets cancer, with NF-[kappa] B as the matchmaker. Nat. Immunol. 12, 715-723 (2011).
30. Lee, T. L. et al. A novel nuclear factor-κ B gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status. Clin. Cancer. Res. 13, 5680-5691 (2007).
31. Kaser, A., Zeissig, S. & Blumberg, R. S. Inflammatory Bowel Disease. Annu. Rev. Immunol. 28, 573-621 (2010).
32. Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296 (2004).
33. Schwitalla, S. et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152, 25-38 (2013).
34. Geldmeyer-Hilt, K. et al. 1, 25-dihydroxyvitamin D3 impairs NF-κ B activation in human naive B cells. Biochem. Biophys. Res. Commun. 407, 699-702 (2011).
35. Dong, X. et al. Direct Transcriptional Regulation of RelB by 1α , 25-Dihydroxyvitamin D3 and Its Analogs: Physiologic and therapeutic implications for dendritic cell function. J. Biol. Chem. 278, 49378-49385 (2003).
36. Arabi, A. et al. Proteomic screen reveals Fbw7 as a modulator of the NF-κ B pathway. Nat. Commun. 3, 976 (2012).
37. Fukushima, H. et al. SCF Fbw7 Modulates the NFκ B Signaling Pathway by Targeting NFκ B2 for Ubiquitination and Destruction. Cell. Rep. 1, 434-443 (2012).
38. Salehi-Tabar, R. et al. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. P.N.A.S. 109, 18827-18832 (2012).
39. Welcker, M. & Clurman, B. E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer. 8, 83-93 (2008).
40. Cheng, Y. & Li, G. Role of the ubiquitin ligase Fbw7 in cancer progression. Cancer. Metast. Rev. 31, 75-87 (2012).
41. Villeneuve, N. F., Lau, A. & Zhang, D. D. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antiox. Redox. Signal. 13, 1699-1712 (2010).
42. Akhoondi, S. et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 67, 9006-9012 (2007).
43. Wang, Z. et al. Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett. 586, 1409-1418 (2012).
44. Welcker, M. & Clurman, B. E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 8, 83-93 (2008).
45. Hao, B., Oehlmann, S., Sowa, M. E., Harper, J. W. & Pavletich, N. P. Structure of a Fbw7-Skp1-cyclin E complex: multisitephosphorylated substrate recognition by SCF ubiquitin ligases. Mol. Cell. 26, 131-143 (2007).
46. Welcker, M. & Clurman, B. E. Fbw7/hCDC4 dimerization regulates its substrate interactions. Cell. Div. 2, doi: 10.1186/1747- 1028-2-7 (2007).
47. Wu, S. et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-κ B activity in intestine. Am. J. Pathol. 177, 686-697 (2010).
48. An, B.-S. et al. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol. Cell. Biol. 30, 4890-4900 (2010).
49. Welcker, M. & Clurman, B. E. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4. J. Biol. Chem. 280, 7654-7658 (2005).
50. Koepp, D. M. et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294, 173-177 (2001).
51. Olson, B. L. et al. SCFCdc4 acts antagonistically to the PGC-1α transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes. Dev. 22, 252-264 (2008).
52. Inuzuka, H. et al. SCF FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 471, 104-109 (2011).
53. Mao, J.-H. et al. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 321, 1499-1502 (2008).
54. Galli, F. et al. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J. Cell. Science 123, 2423-2433 (2010).
55. Orlicky, S., Tang, X., Willems, A., Tyers, M. & Sicheri, F. Structural Basis for Phosphodependent Substrate Selection and Orientation by the SCF Cdc4 Ubiquitin Ligase. Cell 112, 243-256 (2003).
56. Ten, R. et al. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. EMBO J. 11, 195 (1992).
57. Liptay, S., Schmid, R. M., Nabel, E. G. & Nabel, G. J. Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation. Mol. Cell. Biol. 14, 7695-7703 (1994).
58. Wang, Z. et al. Emerging roles of the FBW7 tumour suppressor in stem cell differentiation. EMBO Rep. 13, 36-43 (2012).
59. Crusio, K., King, B., Reavie, L. & Aifantis, I. The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation. Oncogene 29, 4865-4873 (2010).
60. Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154-1157 (2011).
61. He, L. et al. Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma. Cancer. Discov. 3, 324-337 (2013).
62. Ang, X. L. & Harper, J. W. SCF-mediated protein degradation and cell cycle control. Oncogene 24, 2860-2870 (2005).
63. Wu, R.-C., Feng, Q., Lonard, D. M. & O'Malley, B. W. SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 129, 1125-1140 (2007).
64. Louie, M. C., Revenko, A. S., Zou, J. X., Yao, J. & Chen, H.-W. Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity. Mol. Cell. Biol. 26, 3810-3823 (2006).